No abstract

The general objective of this study was to identify and prioritize the critical success factors required for the adoption of a system to create value for pharmaceutical supply chain stakeholders, and the pharmaceutical supply network as a whole, by using a multi-perspective framework that combines elements of the technology–organization–environment (TOE) contexts for enterprises. The methodology is based on a literature review and expert interviews following the analytic hierarchy process (AHP). This paper identifies and prioritizes 18 critical success factors from three categories: technological, organizational, and environmental. From a practical point of view, this research contributes to the literature by providing expert insight on the topic of drug traceability, especially in terms of how possible values can be captured by companies.

This study aims to identify and analyze the enabling factors and strategies for the structuring and diffusion of a circular business model. Circular model structuring involves several actors, challenges, and barriers. In this context, the present study allows discussion of the business structure in line with the principles of circularity and can contribute by mapping the factors and strategies to be worked for business development in the circular context, providing an overview and guidance for academics, businesspeople, and professionals. Through a case study method, the research allowed identification of the factors and an in-depth understanding of the strategies and drivers of circular business models; from the empirical research, it will be possible to identify opportunities that align with what is already known, but also what may be specific to the context of emerging countries to enable the circular model.

No abstract

No abstract